Dentists in Salem, WI Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. Dwight Simmons, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 27620 75th St, Suite 3, Salem, WI 53168 Phone: 262-843-1808 |
Valentin Cuarto Iii, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 27620 75th St, Suite 3, Salem, WI 53168 Phone: 262-843-1808 Fax: 262-843-1908 |
Matthew Mueller Dentist Medicare: Not Enrolled in Medicare Practice Location: 7137 236th Ave Ste 108, Salem, WI 53168 Phone: 262-843-4643 |
Dr. Chadi Farag Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 25620 75th Street, Salem, WI 53168 Phone: -- |
Dr. Jeffrey L Sorensen, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 24418 75th St, Salem, WI 53168 Phone: 262-843-2004 Fax: 262-843-2832 |
Dr. James Charles Fulmer, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7137 236th Avenue, Suite 108, Salem, WI 53168 Phone: 262-843-4643 |
News Archive
Numerous experts to attend Global Conference for Collaboration and Development on Regenerative Life Science in Beijing
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
Study provides new evidence for anti-cirrhotic effects of GENFIT's GFT505
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that a recent study provides new evidence for anti-cirrhotic effects of GFT505 in the context of NASH.
NCMHD announces $3.8M grant for research on minority recruitment in cancer clinical trials
The University of Minnesota Medical School today announced the details of a $3.8 million grant by the National Institutes of Health's National Center on Minority Health and Health Disparities for research focused on minority recruitment and retention in cancer clinical trials.
Larger trial study needed to decide fate of niacin
Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol).
› Verified 9 days ago